| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | -1.85% | -1.45% | -0.40% | +0.09% | — |
| 14d | 4 | +50.00% | -2.31% | -2.80% | +0.49% | +1.16% | — |
| 30d | 4 | +100.00% | -10.07% | -5.21% | -4.86% | -2.87% | — |
| 60d | 4 | +100.00% | -11.32% | +5.12% | -16.44% | -14.98% | — |
| 90d | 4 | +100.00% | -8.92% | +9.30% | -18.55% | -18.55% | — |
| 180d | 4(4 pending) | — | — | — | — | — | — |
| 1y | 4(4 pending) | — | — | — | — | — | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 1,541 | $519.00 | $799.8K | 11,001 | Jul 2, 2026 | Jul 7, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 2,633 | $498.42 | $1.31M | 12,489 | Mar 11, 2026 | Mar 13, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 2,437 | $475.30 | $1.16M | 15,122 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 2,500 | $486.35 | $1.22M | 19,969 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE10b5-1 10b5-1 plan | 2,410 | $489.00 | $1.18M | 17,559 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE EVP, Chief Commercial Officer | 873 | $485.11 | $423.5K | 22,469 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | PURCHASEGRANT Stock grant | 4,962 | — | — | 24,490 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE EVP, Chief Commercial Officer | 1,148 | $483.75 | $555.3K | 23,342 | Feb 17, 2026 | Feb 19, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE EVP, Chief Commercial Officer | 2,283 | $487.76 | $1.11M | 19,528 | Feb 13, 2026 | Feb 18, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | SALE EVP, Chief Commercial Officer | 1,127 | $468.41 | $527.9K | 21,811 | Feb 10, 2026 | Feb 12, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | PURCHASEGRANT Stock grant | 2,080 | — | — | 22,938 | Jan 22, 2026 | Jan 26, 2026 ↗ | View → |
| VRTX VERTEX PHARMACEUTICALS INC / MA | PURCHASEGRANT Stock grant | 4,720 | — | — | 20,858 | Jan 22, 2026 | Jan 26, 2026 ↗ | View → |